These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 9676073)
21. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study]. Mousny M; Allington N Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416 [TBL] [Abstract][Full Text] [Related]
22. [Botulinum toxin as a treatment for infantile cerebral palsy]. Pascual-Pascual SI; Sánchez de Muniain P; Roche MC; Pascual-Castroviejo I Rev Neurol; 1997 Sep; 25(145):1369-75. PubMed ID: 9377292 [TBL] [Abstract][Full Text] [Related]
23. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study. Lai JM; Francisco GE; Willis FB Adv Ther; 2009 Feb; 26(2):241-8. PubMed ID: 19194671 [TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
25. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study. Buyukavci R; Akturk S; Ersoy Y Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486 [TBL] [Abstract][Full Text] [Related]
26. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy. Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658 [TBL] [Abstract][Full Text] [Related]
27. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report. Cousins E; Ward AB; Roffe C; Rimington LD; Pandyan AD Phys Ther; 2009 Jul; 89(7):688-97. PubMed ID: 19482901 [TBL] [Abstract][Full Text] [Related]
28. [Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury]. Xing ST; Wang D; Wen XH; Wu ZQ; Sun Q; Zhang DW; Cheng Y; Yan D; Yu F Zhongguo Gu Shang; 2010 May; 23(5):350-3. PubMed ID: 20575288 [TBL] [Abstract][Full Text] [Related]
29. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. Farina S; Migliorini C; Gandolfi M; Bertolasi L; Casarotto M; Manganotti P; Fiaschi A; Smania N Funct Neurol; 2008; 23(2):87-91. PubMed ID: 18671909 [TBL] [Abstract][Full Text] [Related]
30. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy. Dursun N; Dursun E; Alican D Int J Clin Pract; 2002 Oct; 56(8):564-7. PubMed ID: 12425363 [TBL] [Abstract][Full Text] [Related]
31. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians). Bensmail D; Hanschmann A; Wissel J J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450 [TBL] [Abstract][Full Text] [Related]
32. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity. Turkel CC; Bowen B; Liu J; Brin MF Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213 [TBL] [Abstract][Full Text] [Related]
33. Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia--report of 19 cases. Hecht MJ; Stolze H; Auf dem Brinke M; Giess R; Treig T; Winterholler M; Wissel J; Mov Disord; 2008 Jan; 23(2):228-33. PubMed ID: 17999430 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of spasticity with botulinum toxin]. Mémin B; Pollak P; Hommel M; Perret J Rev Neurol (Paris); 1992; 148(3):212-4. PubMed ID: 1604136 [TBL] [Abstract][Full Text] [Related]
35. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb. Turner-Stokes L; Ashford S Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605 [TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes. Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438 [TBL] [Abstract][Full Text] [Related]
37. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study. Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525 [TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications. Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354 [TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980 [TBL] [Abstract][Full Text] [Related]
40. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study. Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]